And in the final analysis, who makes the rules in this game? And who reserves the right to change them, the guidance is, after all is cogitated over, a general guidance only.
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-168
-
- There are more pages in this discussion • 687 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $3.862M | 4.054M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 31747 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 95079 | 13 |
View Market Depth
| Last trade - 15.46pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |